Search - tctmd.com

Displaying 1 - 20 of 79

Sort: Relevancy | Date

News Daily News

High Aerobic Fitness Linked to Less Chronic Disease in Later Life

Michael O'Riordan

October 10, 2025

News Conference News ESC 2025

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Michael O'Riordan

September 10, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Daily News

CCTA Bests CV Risk Scores for Bolstering Lifestyle Changes, Medication Uptake

Yael L. Maxwell

June 25, 2025

News Conference News European Congress on Obesity 2025

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Michael O'Riordan

May 13, 2025

News Conference News European Congress on Obesity 2025

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Michael O'Riordan

May 12, 2025

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Features

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Michael O'Riordan

October 21, 2024

News Daily News

Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction

Todd Neale

October 15, 2024

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Daily News

Schoolwide Intervention May Improve Obesity Outcomes Over Time

Yael L. Maxwell

July 29, 2024

News Daily News

Study IDs Patients Most Likely to Quit Smoking After ASCVD Event

Yael L. Maxwell

February 14, 2024

News Daily News

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

L.A. McKeown

February 13, 2024

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

News Daily News

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Michael O'Riordan

December 08, 2023

News Conference News ESC 2023

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

Michael O'Riordan

September 01, 2023

News Daily News

A Mix of Aerobic and Strength Exercise Is Best for Boosting Survival

Caitlin E. Cox

August 09, 2023

News Daily News

LDL Control Remains Poor in CAD Patients: NHANES

Michael O'Riordan

July 05, 2023

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

News Daily News

Third-Trimester Preeclampsia Screening Still Worthwhile, Data Suggest

Caitlin E. Cox

April 11, 2023

Advertisement

High Aerobic Fitness Linked to Less Chronic Disease in Later Life

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

CCTA Bests CV Risk Scores for Bolstering Lifestyle Changes, Medication Uptake

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

December 2024 Dispatch for the CV Team

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Schoolwide Intervention May Improve Obesity Outcomes Over Time

Study IDs Patients Most Likely to Quit Smoking After ASCVD Event

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

A Mix of Aerobic and Strength Exercise Is Best for Boosting Survival

LDL Control Remains Poor in CAD Patients: NHANES

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Third-Trimester Preeclampsia Screening Still Worthwhile, Data Suggest

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content